---
title: "Synopsys executives sold $51 million of stock before S&P dropped its leverage guardrail"
description: "S&P's October 26 upgrade to BBB+ dropped Synopsys's leverage guardrail and cleared up to half its cash flow for buybacks. The CEO and CFO had already sold about $11 million of stock between them, and Cadence's record $8.2 billion backlog shows which of the two EDA leaders is compounding faster."
publisher: "The Inference"
section: "Chips"
published: 2026-10-29T14:30:22.179Z
modified: 2026-10-29T14:30:22.179Z
canonical: https://theinference.org/article/synopsys-executives-sold-51-million-of-stock-before-s-p-dropped-its-leverage-guardrail
language: en
keywords: "Synopsys, Cadence, EDA, Insider Trading, Credit Ratings"
---

# Synopsys executives sold $51 million of stock before S&P dropped its leverage guardrail

> S&P's October 26 upgrade to BBB+ dropped Synopsys's leverage guardrail and cleared up to half its cash flow for buybacks. The CEO and CFO had already sold about $11 million of stock between them, and Cadence's record $8.2 billion backlog shows which of the two EDA leaders is compounding faster.

## The upgrade grades the borrowing, not the demand

On October 26 [S&P Global Ratings](https://theinference.org/markets/companies/s-p-global-ratings) [raised Synopsys to BBB+ from BBB with a stable outlook](https://ca.finance.yahoo.com/news/p-lifts-synopsys-bbb-chip-202811927.html), on "strengthening long-term operating momentum" after the company's analyst day [1]. The same note recorded three facts that matter more than the notch: management stepped away from a prior goal of keeping net leverage below 1x, the company can now direct as much as 50% of cash flow into share repurchases, and the path to the next upgrade runs through leverage held below 2x [1].

An agency removing a balance-sheet guardrail while the borrower loads cash into its own stock is not a forecast of AI demand. It is a license to lever.

## Twenty-two days of filings: a buyback, two executive sales

October 5: the board authorizes [a $1 billion accelerated repurchase](https://theinference.org/article/synopsys-buys-1-billion-of-its-own-stock-after-insiders-sold-38-million), about 1.1% of the 191.6 million shares outstanding [2][3]. October 6: chief financial officer [Sudhindra Kankanwadi](https://theinference.org/markets/people/sudhindra-kankanwadi) sells 9,170 shares at $500.00 for $4.59 million, cutting his direct stake by 28.76% [2]. October 15: chief executive [Sassine Ghazi](https://theinference.org/markets/people/sassine-ghazi) sells 14,604 shares at $462.84 for $6.76 million, 15.97% of his holding, under a pre-arranged 10b5-1 plan [2]. Insider sales across 90 days total $51.4 million [2], and the founder and executive chairman, Aart de Geus, had already sold 24,641 shares for $10.34 million on September 1 [3].

*Chart: **Synopsys reports a 14% operating margin against a 50% target for 2030** Bars showing Synopsys GAAP operating margin by fiscal quarter from April 2025 to July 2026, all between 5 and 15 percent, with a reference line at 50 percent marking management's 2030 operating margin target.*

*Synopsys GAAP operating margin by fiscal quarter, percent of revenue, fiscal quarters ended April 2025 through July 2026; the fiscal 2026 third quarter closed July 31, 2026, and carries Ansys acquisition costs in the margin. The 50 percent reference is management's 2030 operating margin target as restated by S&P on October 26, 2026, on the company's own margin basis, not a figure any reported period reaches. Sources: Synopsys quarterly figures from SEC filings [4]; S&P Global Ratings note [1]. [4][1]*

## Management's exhibits: mid-teens to 2029, 50% by 2030

S&P's note carries the bull case: mid-teens revenue growth now modeled through 2029, up from about 10%, a 49% EBITDA margin by 2029, and company targets of 15% annualized growth with 50% operating margins by 2030 [1]. Ansys integration runs a year ahead of plan, with $400 million of cost synergies pulled into fiscal 2027 [1].

An [Amazon IP contract worth more than $1 billion](https://theinference.org/article/amazon-s-aws-pays-synopsys-over-1-billion-for-chip-blueprints-to-build-past-nvidia) broadens licensing [1], and agentic workflows are framed as a volume catalyst that triggers more verification and simulation rather than a replacement [1]. All of it sits beside the [OpenAI revenue-share deal signed September 30](https://theinference.org/article/synopsys-promised-50-margins-then-agreed-to-share-the-new-revenue-with-openai), whose split remains undisclosed [3].

## The rival printed first, and organically

The other camp scores the tape. [Synopsys](https://theinference.org/markets/companies/synopsys) carries a $92.35 billion market cap on 85x trailing earnings, with fiscal 2026 EPS guided to $15.04-$15.10, about 32x on its own guidance [2]. Its reported 42.4% quarterly growth includes Ansys; the step from $1.74 billion to $2.26 billion of quarterly revenue arrived with the acquisition [4], and nobody outside the company can yet split organic from bought.

*Chart: **The step to $2.26 billion arrived with Ansys, not before it** Line chart of Synopsys quarterly revenue across twelve quarters, holding between 1.455 and 1.74 billion dollars through mid-2025, then jumping to 2.255 billion in the quarter ended October 31, 2025 and reaching 2.477 billion by the quarter ended July 31, 2026.*

*Synopsys quarterly revenue, US dollars in billions, labeled by calendar quarter; Synopsys's fiscal year ends October 31, so calendar Q3 '25 is its fiscal fourth quarter, the first with a full Ansys contribution after the July 2025 close. The quarter ended July 31, 2026 brought $2.477 billion, up 42.4 percent year over year including Ansys. Sources: Synopsys quarterly figures from SEC filings [4]. [4]*

[Cadence](https://theinference.org/markets/companies/cadence), the rival that reported on October 26, [grew 22% to $1.633 billion with every product line up double digits](https://www.design-reuse.com/news/202531346-cadence-reports-third-quarter-2026-financial-results/), EDA 20%, IP 24%, system design and analysis 30%, lifted backlog to a record $8.2 billion with $4.2 billion converting within 12 months, and raised full-year growth guidance for the third time this year, to about 21% [5][6].

## Cadence's AI bill is already in the margin

Its AI bill is visible too: non-GAAP operating margin slipped to 44.1% from 47.6%, and Maestro, the model line behind the pitch, reaches select customers in early access only this quarter, its vendor-reported gains still unvalidated in production [5][8]. The stock at 35x forward earnings sits under its five-year average of 43x [6].

*Chart: **Cadence's revenue growth reaccelerated through 2026, from 6% to 24%** Line chart of Cadence quarterly revenue in billions of dollars across ten quarters, rising from 1.009 to 1.584, with year-over-year growth slowing to 6.2 percent in late 2025 and reaccelerating to 24.2 percent by the June 2026 quarter.*

*Cadence quarterly revenue, US dollars in billions, fiscal quarters ended March 2024 through June 2026. The September 2026 quarter reported on October 26 came in at $1.633 billion, up 22 percent year over year. Sources: Cadence quarterly figures from SEC filings [9]; Cadence Q3 2026 press release [5]. [9][5]*

## The defense: plans filed in advance, a balance sheet barely touched

Both executive sales ran under pre-arranged 10b5-1 plans, and the filings state no motive [2][3]. Debt-to-equity is 0.29 with a quick ratio of 1.24, so the lever is barely pulled [2]. Motley Fool Asset Management [opened a $5.75 million position in the same quarter](https://www.marketbeat.com/instant-alerts/filing-13219-shares-in-synopsys-inc-snps-bought-by-motley-fool-asset-management-llc-2026-10-29/) [2], and a physics-locked moat with usage-based pricing can credibly carry a mid-teens compounder [1]. [Cadence](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000813672)'s caveat cuts both ways: agent revenue has not been separated from underlying tool consumption, so neither camp can yet price the agentic shift [7].

*Chart: **Named executives account for $21.7 million of the $51.4 million sold in 90 days** Bars ranking Synopsys insider sales over 90 days: other insiders about 29.7 million dollars, founder Aart de Geus 10.34 million, chief executive Sassine Ghazi 6.76 million, and chief financial officer Sudhindra Kankanwadi 4.59 million, with the three named executives drawn in colour.*

*Synopsys insider sales by seller, US dollars in millions, over the 90 days to October 29, 2026. The $29.7 million for other insiders is the $51.4 million 90-day total minus the three named sales. All three named sales ran under pre-arranged 10b5-1 plans. Sources: MarketBeat filing alerts [2]; The Inference, October 7 [3]. [2][3]*

## The verdict watch: the organic print

The camps collide on one number. Cadence's 22% is organic [5]; Synopsys's mid-teens promise is the floor under a 32x multiple [1][2]. The reading that decides it is Synopsys's fiscal fourth-quarter report, the quarter that closed on October 31, measured against the $15.04-$15.10 full-year guide [2]; Cadence's own fourth-quarter guide, $1.695-$1.725 billion of revenue at a 44-45% non-GAAP margin, lands first [5]. Until that print separates organic growth from Ansys, BBB+ grades the borrowing, and [Cadence's $8.2 billion backlog](https://finance.yahoo.com/markets/stocks/articles/cadence-soars-6-record-8-165331635.html) grades the business [2][5].

## Takeaway

S&P's BBB+ upgrade scrapped Synopsys's sub-1x leverage cap and freed up to half its cash flow for buybacks, but with $51.4 million of insider sales in 90 days and Ansys still blurring organic growth, the fiscal Q4 print against the $15.04 to $15.10 EPS guide is the number that decides it.

## Sources

1. [Yahoo Finance Canada (Investing.com), S&P lifts Synopsys to 'BBB+' as chip-design leader capitalizes on AI demand, 26 October 2026](https://ca.finance.yahoo.com/news/p-lifts-synopsys-bbb-chip-202811927.html)
2. [MarketBeat, 13,219 Shares in Synopsys, Inc. Bought by Motley Fool Asset Management LLC, 29 October 2026](https://www.marketbeat.com/instant-alerts/filing-13219-shares-in-synopsys-inc-snps-bought-by-motley-fool-asset-management-llc-2026-10-29/)
3. [The Inference, Synopsys buys $1 billion of its own stock after insiders sold $38 million, 7 October 2026](https://theinference.org/article/synopsys-buys-1-billion-of-its-own-stock-after-insiders-sold-38-million)
4. [Synopsys, quarterly figures from its SEC filings, retrieved 29 October 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000883241)
5. [Cadence press release via Design And Reuse, Cadence Reports Third Quarter 2026 Financial Results, 29 October 2026](https://www.design-reuse.com/news/202531346-cadence-reports-third-quarter-2026-financial-results/)
6. [Yahoo Finance, Cadence Soars 6% on Record $8.2 Billion Backlog, Raising Outlook For the Third Time This Year, 28 October 2026](https://finance.yahoo.com/markets/stocks/articles/cadence-soars-6-record-8-165331635.html)
7. [The Futurum Group, Cadence Q3 FY 2026: AI Agents Expand Design Workflow Adoption, 28 October 2026](https://futurumgroup.com/insights/cadence-q3-fy-2026-ai-agents-expand-design-workflow-adoption/)
8. [CIO.com, Cadence Maestro puts domain-trained AI agents to work for chip design, October 2026](https://www.cio.com/article/4241825/cadence-maestro-puts-domain-trained-ai-agents-to-work-for-chip-design.html)
9. [Cadence, quarterly figures from its SEC filings, retrieved 29 October 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000813672)


---

Synopsys executives sold $51 million of stock before S&P dropped its leverage guardrail — The Inference. Canonical: https://theinference.org/article/synopsys-executives-sold-51-million-of-stock-before-s-p-dropped-its-leverage-guardrail